Bio Vitos Pharma
0,102
SEK
+1,5 %
Mindre end 1K følgere
BIOVIT
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Finansielt overblik og estimater
Ownership
+1,5%
-15,42%
-57,71%
-79,7%
-33,22%
-36,76%
-90,97%
-96,66%
-97,93%
Bio Vitos Pharma operates in the medical technology industry. The company develops and commercializes products for the detection of hemolysis in blood samples. The company has developed products that ensure that the hemolysis is detected at an early stage, which means that the blood sample can be taken care of immediately. The company also develops digital reading that is used as a complement to the main product. Bio Vitos Pharma was founded in 2010 and is headquartered in Karlstad.
Læs mereMarkedsværdi
4 mio. SEK
Aktieomsætning
1,65 t SEK
Omsætning
410 t
EBIT %
-4.385,37 %
P/E
-
Udbytteafkast, %
-
Finanskalender
13.5
2025
Delårsrapport Q1'25
14.5
2025
Generalforsamling '25
28.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
Bio Vitos Pharma AB: KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer
Bio Vitos Pharma AB: The European Patent Office EPO grants patent that is important to Bio Vitos Pharma
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools